Antiviral hepatitis and antiretroviral drug interactions

This publication has 73 references indexed in Scilit:

• New Hopes for HIV and HCV Coinfection in 2004
  HIV Research & Clinical Practice, 2004
• Management of hepatitis B in patients coinfected with the human immunodeficiency virus
  European Journal of Clinical Microbiology & Infectious Diseases, 2004
• Interferon‐Ribavirin in Association with Stavudine Has No Impact on Plasma Human Immunodeficiency Virus (HIV) Type 1 Level in Patients Coinfected with HIV and Hepatitis C Virus: A CORIST‐ANRS HC1 Trial
  Clinical Infectious Diseases, 2003
• Emerging Role of Riboflavin in the Treatment of Nucleoside Analogue-Induced Type B Lactic Acidosis
  AIDS Patient Care and STDs, 2001
• Symptomatic Lactic Acidosis in Hospitalized Antiretroviral‐Treated Patients with Human Immunodeficiency Virus Infection: A Report of 12 Cases
  Clinical Infectious Diseases, 2001
• Direct determination of phosphorylated intracellular anabolites of stavudine (d4T) by liquid chromatography/tandem mass spectrometry
  Rapid Communications in Mass Spectrometry, 2001
• The intracellular activation of lamivudine (3TC) and determination of 2′-deoxycytidine-5′-triphosphate (dCTP) pools in the presence and absence of various drugs in HepG2 cells
  Published by Wiley ,2000
• Once‐Daily Combination Therapy with Emtricitabine, Didanosine, and Efavirenz in Human Immunodeficiency Virus–Infected Patients
  The Journal of Infectious Diseases, 2000
• Lactic Acidosis Associated with Stavudine Administration: A Report of Five Cases
  Clinical Infectious Diseases, 2000
• Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
  The Lancet, 1999